Home / Generics

Generics

News

US approval for prostate cancer formulation and impotence generics posted 22/06/2018

The US Food and Drug Administration (FDA) has approved generics of tadalafil, used to treat male impotence, and a new abirate...

Aurobindo and Lannett expand their generics portfolios posted 15/06/2018

Both Indian generics maker Aurobindo Pharma (Aurobindo) and US generics company Lannett have announced efforts to increase th...

Price of leukaemia drug in Japan halved posted 25/05/2018

Japanese drugmaker Ohara Pharmaceutical has reduced the price of its leukaemia generic imatinib to about half the price of th...

Hikma launches HIV generic ritonavir in the US posted 18/05/2018

Jordan-based drugmaker Hikma Pharmaceuticals (Hikma) announced on 20 March 2018 that its wholly owned US subsidiary West-Ward...

Alvogen receives European approval for generic lenalidomide posted 11/05/2018

US generics company Alvogen announced on 24 April 2018 that it had successfully concluded multiple registration procedures fo...

 

Research

Doctors’ perceptions of generics in Guadeloupe and Martinique posted 15/06/2018

Doctors in Guadeloupe and Martinique are not hostile towards generics but still mostly prescribe brand-name drugs due to pati...

Generics market failures and non-profit manufacturing posted 08/06/2018

Competition usually keeps the price of generics well below that of brand-name drugs. However, when there is little or no comp...

Antitrust activities in the pharmaceutical industry posted 01/06/2018

High prices of prescription drugs have been highlighted as reducing access to essential drugs and have recently gained notori...

Encouraging generics could cause high prices posted 25/05/2018

A provision introduced in October 2017 awards eligible drugmakers 180 days of exclusivity to market a generic version of one...

Trends in use of Lipitor after introduction of generic atorvastatin posted 04/05/2018

Big savings can be made after the introduction of generics, especially when it comes to high volume categories, such as stati...

 

General

FDA publishes list of companies that block generics posted 22/06/2018

The US Food and Drug Administration (FDA) announced on 17 May 2018 that it had published a list of companies that block gener...

FDA to boost generics and change drug rebates to lower prices posted 08/06/2018

In two recent speeches US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has outlined plans to fight back aga...

China to exempt cancer drugs from import taxes posted 08/06/2018

Under a new policy that took effect on 1 May 2018, China will exempt as many as 28 medicines, including all cancer drugs, mad...

EMA collaboration on oversight of API makers posted 08/06/2018

The European Medicines Agency (EMA) announced on 12 April 2018 that it had published the International API inspection program...

Generics companies defend against illegal ‘pay-for-delay’ charges posted 20/04/2018

In March 2018, pharmaceutical companies in the US and Europe have had to defend themselves against antitrust charges. Illegal...